Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Telomere fusions and their detection of dysplasia and/or cancer

Telomere fusions and their detection of dysplasia and/or cancer

US Patent 12018332 · Granted Jun 25, 2024

Estimated economic value: $44,657,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic method using PALB22016
Aberrantly methylated genes in pancreatic cancer2014
Methylated gene biomarkers for detecting cancer2011
Aberrantly methylated genes in pancreatic cancer2009
Differentially methylated sequences in pancreatic cancer2006